American Medical Software Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • American Medical Software's estimated annual revenue is currently $507.5k per year.(i)
  • American Medical Software's estimated revenue per employee is $72,500

Employee Data

  • American Medical Software has 7 Employees.(i)

American Medical Software's People

NameTitleEmail/Phone
1
OwnerReveal Email/Phone
2
Technical DirectorReveal Email/Phone
3
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$872.9M4300N/AN/AN/A
#2
$1500M5609-10%$100M$2.2B
#3
$15.5M111-7%$157.5MN/A
#4
$16M1238%N/AN/A
#5
$1573.2M78585%$40MN/A
#6
$36.4M2285%N/AN/A
#7
$124.5M6872%N/AN/A
#8
$23.2M154-8%$60.7MN/A
#9
$317.9M15888%$332.6M$1B
#10
$22.3M140N/AN/AN/A
#11
$1.3M15N/AN/AN/A
#12
$5.6M48N/AN/AN/A
#13
$306.2M810N/AN/AN/A
#14
$160.3M475N/AN/AN/A
#15
$79.4M4319%$10.7MN/A
#16
$80.3M47627%N/AN/A
#17
$3.5M30-9%N/AN/A
#18
$62.4M344N/AN/AN/A
#19
$48.4M163N/AN/AN/A
#20
$1.5M17N/AN/AN/A
Add Company

What Is American Medical Software?

keywords:N/A

N/A

Total Funding

7

Number of Employees

$507.5k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

American Medical Software News

2022-04-20 - Medical Billing Software Market forces, Consumption ...

Insta Health Solutions; bflow Solutions; American Medical Software; Meditab Software; Kareo; TotalMD; Navicure; Insta Medical Care. Get a sample...

2022-04-20 - Medical Scheduling Systems Market Growth 2022-2030| Key ...

Medical Scheduling Systems Market Growth 2022-2030| Key Players – TimeTrade Systems, Yocale, American Medical Software, Voicent Communications.

2022-04-17 - Global Medical Scheduling Tools Market 2022 Industry ...

Global Medical Scheduling Tools Market 2022 Industry Challenges by Players – TimeTrade Systems, Yocale, American Medical Software, Voicent...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M80%N/A
#2
$0.9M100%N/A
#3
$1.3M12-71%N/A
#4
$2.8M148%N/A
#5
$2.3M148%N/A